These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7830247)

  • 21. A simplified approach for estimating skin permeation parameters from in vitro finite dose absorption studies.
    Lehman PA
    J Pharm Sci; 2014 Dec; 103(12):4048-4057. PubMed ID: 25324199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion modelling of percutaneous absorption kinetics. Predicting urinary excretion from in vitro skin permeation tests (IVPT) for an infinite dose.
    Liu X; Yousef S; Anissimov YG; van der Hoek J; Tsakalozou E; Ni Z; Grice JE; Roberts MS
    Eur J Pharm Biopharm; 2020 Apr; 149():30-44. PubMed ID: 32018051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics and control of percutaneous drug absorption in the presence of epidermal turnover.
    Simon L; Goyal A
    J Pharm Sci; 2009 Jan; 98(1):187-204. PubMed ID: 18481307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiologically based mathematical modelling of solute transport within the epidermis and dermis.
    Calcutt JJ; Anissimov YG
    Int J Pharm; 2019 Oct; 569():118547. PubMed ID: 31377408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of skin thickness on the in vitro permeabilities of drugs through Sprague-Dawley rat or Yucatan micropig skin.
    Takeuchi H; Ishida M; Furuya A; Todo H; Urano H; Sugibayashi K
    Biol Pharm Bull; 2012; 35(2):192-202. PubMed ID: 22293349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers.
    He N; Warner KS; Higuchi WI; Li SK
    Int J Pharm; 2005 Jun; 297(1-2):9-21. PubMed ID: 15907593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro human topical bioactive drug transdermal absorption: estradiol.
    Xing MM; Hui X; Zhong W; Pan N; Yaghmaie F; Maibach HI
    Cutan Ocul Toxicol; 2009; 28(4):171-5. PubMed ID: 19888886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico prediction of percutaneous absorption and disposition kinetics of chemicals.
    Chen L; Han L; Saib O; Lian G
    Pharm Res; 2015 May; 32(5):1779-93. PubMed ID: 25407547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does epidermal turnover reduce percutaneous penetration?
    Reddy MB; Guy RH; Bunge AL
    Pharm Res; 2000 Nov; 17(11):1414-9. PubMed ID: 11205736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin as an active metabolizing barrier I: Theoretical analysis of topical bioavailability.
    Ando HY; Ho NF; Higuchi WI
    J Pharm Sci; 1977 Nov; 66(11):1525-8. PubMed ID: 915724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theoretical analysis of the effect of cutaneous metabolism on skin permeation of parabens based on a two-layer skin diffusion/metabolism model.
    Seko N; Bando H; Lim CW; Yamashita F; Hashida M
    Biol Pharm Bull; 1999 Mar; 22(3):281-7. PubMed ID: 10220285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin.
    Gysler A; Kleuser B; Sippl W; Lange K; Korting HC; Höltje HD; Korting HC
    Pharm Res; 1999 Sep; 16(9):1386-91. PubMed ID: 10496654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skin penetration of nonsteroidal antiinflammatory drugs out of a lipophilic vehicle: influence of the viable epidermis.
    Wenkers BP; Lippold BC
    J Pharm Sci; 1999 Dec; 88(12):1326-31. PubMed ID: 10585230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual sorption model for the nonlinear percutaneous permeation kinetics of timolol.
    Kubota K; Koyama E; Twizell EH
    J Pharm Sci; 1993 Dec; 82(12):1205-8. PubMed ID: 8308696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose partition coefficient and diffusivity in the lower skin layers.
    Khalil E; Kretsos K; Kasting GB
    Pharm Res; 2006 Jun; 23(6):1227-34. PubMed ID: 16715366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An analytical solution for percutaneous drug absorption: application and removal of the vehicle.
    Simon L; Loney NW
    Math Biosci; 2005 Oct; 197(2):119-39. PubMed ID: 16135370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative permeation studies of nondiluted and diluted betamethasone-17-valerate semisolid formulations through isolated human stratum corneum and artificial skin construct.
    Mitriaikina S; Muller-Goymann CC
    Skin Pharmacol Physiol; 2009; 22(3):142-50. PubMed ID: 19246962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adsorption in stratum corneum and percutaneous penetration of propranolol hydrochloride].
    Liang WQ; Wang WL; Lin W
    Yao Xue Xue Bao; 1992; 27(10):779-84. PubMed ID: 1293927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport of beta-estradiol in freshly excised human skin in vitro: diffusion and metabolism in each skin layer.
    Liu P; Higuchi WI; Ghanem AH; Good WR
    Pharm Res; 1994 Dec; 11(12):1777-84. PubMed ID: 7899244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologically relevant two-compartment pharmacokinetic models for skin.
    McCarley KD; Bunge AL
    J Pharm Sci; 2000 Sep; 89(9):1212-35. PubMed ID: 10944386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.